Pathogens Novel Therapy for Crimean-Congo Hemorrhagic Fever Virus by Global Biodefense Staff June 6, 2021
Pathogens Images of Cells Exposed to COVID-19 Vaccine Reveal Native-Like Coronavirus Spikes by Global Biodefense Staff April 7, 2021
Pathogens EV-D68: Epidemiological Model Links Spread of Respiratory Virus to a Rare, Paralyzing Disease by Global Biodefense Staff March 19, 2021
Preparedness Factors Influencing Health Care Workers’ Willingness to Respond to Duty During Outbreaks and Bioterrorist Event by Global Biodefense Staff March 19, 2021
Medical Countermeasures mRNA Treatment Shows Promise for Stopping Flu and COVID-19 Viruses by Global Biodefense Staff March 19, 2021
Research Humidity in Breath Makes Cotton Masks More Effective at Slowing Spread of SARS-CoV-2 by Global Biodefense Staff March 11, 2021
Pathogens How to Detect When a Virus is Infecting Important Bacterial Populations by Global Biodefense Staff March 11, 2021
Pathogens Can Zika Trigger ADE? New Research Shows How Antibodies Stick To and Block Zika Virus by Global Biodefense Staff March 11, 2021
Public Health Does Your Child Have MIS-C, COVID-19 or Kawasaki Disease? by Global Biodefense Staff March 11, 2021
Medical Countermeasures WRAIR, Duke Scientists Find Evidence of Monoclonal Antibody Activity Against Malaria by Global Biodefense Staff March 5, 2021
Biodetection Coronavirus-Like Particles Could Ensure Reliability of Simpler, Faster COVID-19 Tests by Global Biodefense Staff March 2, 2021
Medical Countermeasures One Drug to Defeat All Filoviruses? by Global Biodefense Staff February 14, 2021
Biosecurity Stopping Zika: Engineering an Alternative to ‘Suicide Mosquitoes’ by Global Biodefense Staff February 14, 2021
Research Macaques Develop Promising Immune Response to SARS-CoV-2 by Global Biodefense Staff February 7, 2021
Biosecurity US Must Unify Atmospheric Biology Research or Risk National Security by Global Biodefense Staff January 30, 2021
Biodetection Self-Swabs vs. Caregiver Swabs for COVID Tests: New Study Shows Similar Accuracy by Global Biodefense Staff January 30, 2021
Medical Countermeasures SARS-CoV-2 Stem-Loop II Motif: Potential Target for Anti-viral Drugs by Global Biodefense Staff January 26, 2021
Pathogens SARS-CoV-2 Reacts to Antibodies of Virus from 2003 SARS Outbreak by Global Biodefense Staff January 26, 2021
Infectious Diseases NSAIDs Might Exacerbate or Suppress COVID-19 Depending on Timing by Global Biodefense Staff January 26, 2021
Pathogens In Tight Spaces, Air Purifiers May Do More Harm Than Good in Spreading Viruses by Global Biodefense Staff January 26, 2021
